Abstract
Many studies have shown that determination of the blood concentrations of cardiac troponin I and T (cTnI and cTnT) offers higher clinical sensitivity and specificity for the diagnosis of cardiac injury than do the standard cardiac protein markers such as creatine kinase (CK) (1)(2). However, the release of cardiac troponins into the blood stream of laboratory animals in response to cardiac insults such as drugs is still not well defined. It was our objective to examine the release of cardiac troponins together with CK by repeat dosing in isoproterenol (ISO)-treated beagle dogs, a routinely used animal model in preclinical studies. ISO is a sympathomimetic agent and β-adrenergic receptor agonist that causes acute cardiac injury at high doses (3). In the present study, 1 male and 1 female beagle dog (9 months old) were given a 1 mg/kg subcutaneous injection of ISO on each of 2 consecutive days. Abnormal pathologic alterations, including severe coagulative necrosis, were observed in both animals. Blood was collected from the jugular vein into collection tubes (Beckon Dickinson) containing EDTA for the analysis of cardiac troponins and into the same type tubes with no additive for CK. The blood concentration of cTnI was measured by a modified Access® AccuTnI™ immunoassay (Beckman-Coulter) performed manually on 96-well plates according to the manufacturer’s recommended experimental conditions. cTnT was determined by an ELISA containing a biotinylated monoclonal cTnT-specific …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.